A Study to Describe Pediatric Influenza Vaccine Coverage

This study has been completed.
Sponsor:
Information provided by:
MedImmune LLC
ClinicalTrials.gov Identifier:
NCT00639418
First received: March 4, 2008
Last updated: November 4, 2011
Last verified: November 2011
  Purpose

The purpose of this study is to describe influenza vaccine coverage in children less than 18 years of age and to examine correlations between in-office influenza vaccine coverage various tactics to increase vaccine coverage.


Condition
Healthy

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: An Observational Study to Describe Pediatric Influenza Vaccine Coverage Among Pediatricians in the U.S.

Resource links provided by NLM:


Further study details as provided by MedImmune LLC:

Primary Outcome Measures:
  • Influenza vaccine coverage in children <18 years of age by age group [ Time Frame: Seasonal: 2007-2011 ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Compliance with the recommended two-dose regimen in vaccinated children [ Time Frame: Seasonal: 2007-2011 ] [ Designated as safety issue: No ]
  • Correlation of office vaccination-related attitudes and activities with actual vaccine coverage [ Time Frame: Seasonal: 2007-2011 ] [ Designated as safety issue: No ]

Estimated Enrollment: 0
Study Start Date: September 2007
Study Completion Date: July 2011
Primary Completion Date: March 2011 (Final data collection date for primary outcome measure)
Groups/Cohorts
1
Children 6 to 23 months
2
Children 24 to 59 months
3
Children 5 to 8 years
4
Children 9 to 17 years

Detailed Description:

To describe influenza vaccine coverage in children less than 18 years of age in practicing pediatricians' offices and family medicine physicians' offices and to examine correlations between in-office influenza vaccine coverage and the use of various tactics to increase vaccine coverage.

  Eligibility

Ages Eligible for Study:   6 Months to 17 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

Up to 100 pediatrician and family medicine physician offices will be selected to participate in the study.

Criteria

Inclusion Criteria:

  • 6 months to 17 years of age
  • Males and females

Exclusion Criteria:

  • None
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00639418

  Show 187 Study Locations
Sponsors and Collaborators
MedImmune LLC
Investigators
Study Director: Seth Toback, M.D. MedImmune LLC
  More Information

Additional Information:
No publications provided

Responsible Party: Seth Toback, M.D., MedImmune, LLC
ClinicalTrials.gov Identifier: NCT00639418     History of Changes
Other Study ID Numbers: MI-MA156
Study First Received: March 4, 2008
Last Updated: November 4, 2011
Health Authority: United States: Food and Drug Administration

Additional relevant MeSH terms:
Influenza, Human
Orthomyxoviridae Infections
RNA Virus Infections
Virus Diseases
Respiratory Tract Infections
Respiratory Tract Diseases

ClinicalTrials.gov processed this record on April 21, 2014